SBI Securities’s Soleno Therapeutics SLNO Stock Holding History

SBI Securities’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-149	Closed	-$4.99K	–	4178
2026 Q1	$4.99K	Buy	149 +66	+80%	+$2.59K	﹤0.01%	2028
2025 Q4	$3.84K	Buy	83 +66	+388%	+$3.62K	﹤0.01%	2131
2025 Q3	$1.15K	Buy	17 +2	+13%	+$148	﹤0.01%	2639
2025 Q2	$1.26K	Sell	15 -2	-12%	-$150	﹤0.01%	2577
2025 Q1	$1.22K	Buy	17 +2	+13%	+$97	﹤0.01%	2500
2024 Q4	$674	Buy	+15	New	+$777	﹤0.01%	2781

SBI Securities's SLNO Position: Q2 2026 in Review

SBI Securities sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 149 shares — an estimated $4.99K sold.

SBI Securities first reported a position in SLNO in Q4 2024 and held it in 6 quarters. The position peaked at $4.99K in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

SBI Securities reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
SBI Securities sold 149 Soleno Therapeutics shares in Q2 2026, an estimated $4.99K.
SBI Securities first reported a position in Soleno Therapeutics in Q4 2024 and held it in 6 quarters.
SBI Securities's Soleno Therapeutics position peaked at $4.99K in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.